Geno1™

Remove bottlenecks, save lives

Reduced
cost

Direct cost savings as well as indirect effects created by increased diagnostics accuracy.

Increased
accuracy

The unique combination of molecular biology, NGS and AI provides market-leading accuracy.

Faster
turn-around-time

Manual stages of work almost fully minimized, enabling unparallelled scalability and processing times.

Geno1™ in detail

The core of Geno1™ is its unique combination of molecular biology, next-generation DNA sequencing (NGS) and artificial intelligence (AI).

Geno1™ addresses the key shortcomings of other NGS-based liquid biopsy solutions through its minimalistic but powerful design, leading to substantially lower test costs, higher test accuracy and faster turn-around-time.

Geno1™ is a unique technology which enables cutting-edge medical technology that is genuinely accessible.

Minimize to maximize

Our unique ligation-based molecular barcoding technology leverages the power of NGS platforms and AI. The laboratory design of Geno1™ has been guided by the principle of minimalism: reduce all processing steps to minimum and make them as simple as possible. Through these design choices, Geno1™ provides a lightweight but powerful molecular counting platform which scales to any number of oncologically relevant targets within any number of patient samples.

The focus can be outside oncology; Geno1™ can be applied to any NGS-based area.

Join our journey

We’re set to saturate the scattered liquid biopsy space with our technology. We offer Geno1™ for out-licensing and are continuously looking for new long-term partnerships.

Join us in democratizing true game-changing technology!